Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2015


Pharmaceutical Microbiology

21 Jan 2015 - 22 Jan 2015 - London, UK



Bookmark and Share


Excellence in the Prevention, Detection and Management of Microorganisms

Set to take place on 21st and 22nd January 2015, the 4th annual event in the sell-out Pharmaceutical Microbiology series will bring together all levels of industry professionals, providing essential insights into the latest advancements in practice and technology, developments in regulation and the global harmonisation of evolving microbiology methods.

Join us as we ask questions such as: What are the best approaches in contamination control? Where does microbiological risk assessment interact with HACCP? How do we develop and manage the sterilisation and validation process? When can we use a scoring system to avoid unnecessary microbiological testing? What are the latest approaches to preventing biofilms? 

Hear presentations from an array of market leaders such as GSK, Genzyme, Abbott, MedImmune and AstraZeneca, address real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. 

TOP KEY SPEAKERS INCLUDE:

  • Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
  • Ruth Daniels, Head of MSAT, Microbiology, Genzyme
  • Sara Gamberini, Molecular Biology Scientist, Merck Serono
  • Hans Noordergraaf, Microbiologist, Abbott Biologicals
  • Thomas Schwartz, Microbiology & Molecular Biology Group Leader, Forschungszentrum Karlsrube Gmbh
  • Tim Eaton, Sterile Manufacturing, Specialist, AstraZeneca
  • Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
  • Phil Duncanson, Director of QC, MedImmune

BUSINESS BENEFITS FOR 2015:

  • Discover the latest in the development and management of sterilisation and validation processes
  • Understand data review and analysis for pharmaceutical microbiology
  • Benefit from listening to developments in bioburden and biofilm control strategies
  • Look in depth at issues of objectionable organism management
  • Hear specialist advice on contamination control and risk assessment to minimise costs and maximise efficiency
  • Share the wisdom of respected consultants and get a regulatory perspective on recent changes and issues under review.

“I have attended the last 2 Microbiology conference and have appreciated that outstanding experts from the pharmaceutical industry, and international academia presented various microbiological aspects with a series of case studies to focus on the practical knowledge, the “know how” which can be directly applied on daily business.  I look forward to attend this new conference in London as it is likely to provide an incredible forum for open discussions with speakers and attendants. - Oliver Chancel, Merial Sas

To download a brochure or to book a place visit: www.pharma-microbiology.com

Alternatively contact the team on Tel +44 (0) 870 9090 711 or email events@smi-online.co.uk 




Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!